GERMANY: BfArM provides support for ongoing clinical trials
Germany reacts to the pandemic with high attention to ongoing clinical trials. According to the government authority BfArM, protocol deviations and changes may occur with the dynamic risk situation and restrictions due to Coronavirus SARS-CoV-2. A dedicated email, CT-COVID@bfarm.de, [...]